Results 221 to 230 of about 81,406 (283)

CD19⁺Ki67⁺B cells regulated by NAMPT as key modulators in triple-negative breast cancer with brain metastasis. [PDF]

Breast Cancer Res
Zhou Q, Zhu Z, Zhao Y, Jing D, Zhang L.
europepmc   +1 more source

SMR Peptide Modulates Tumor-Derived Extracellular Vesicles microRNA and Inflammatory Transcript Signatures in TNBC. [PDF]

Cells
Huang MB, Yan F, Jadoon U, Wu JY, Brena D, Johnson EL, Stiles J, Yang L, Rivers BM, Bond VC.   +9 more
europepmc   +1 more source

TROP2/claudin program mediates immune exclusion to impede checkpoint blockade in breast cancer. [PDF]

J Immunother Cancer
Wu B, Thant W, Bitman E, Liu T, Liu J, Paschalis EI, Patel BK, Nawrocki C, Xu KH, Nieman LT, Ting DT, de Gois Macedo B, Cheng Y, Jiang K, Sun F, Thimmiah N, Sun S, Abelman RO, Bossuyt VI, Isakoff SJ, Spring LM, Bardia A, Ellisen LW.   +22 more
europepmc   +1 more source

Podophyllotoxin sensitizes triple-negative breast cancer cells to CD47-targeted immunotherapy. [PDF]

Cell Insight
Dang J, Song N, Zhou J, Raoof M, Feng M.
europepmc   +1 more source

Combined Treatment with Shuyu Pills and Everolimus Suppresses Triple-Negative Breast Cancer Growth via the PI3K/AKT/mTOR Pathway. [PDF]

Breast Cancer (Dove Med Press)
Zhao J, Luo X, Li H, Cheng Y, Lin X, Xie S.   +5 more
europepmc   +1 more source

Multi-omics analyses related to mitochondria and ageing in triple-negative breast cancer implicate PYCR1 potentiates tumor progression. [PDF]

Cancer Cell Int
Huang JN, Hu J, Shi C, Chu C, Hu H.
europepmc   +1 more source

Overcoming Chemotherapy Resistance in Triple-Negative Breast Cancer with Nanocarrier-Delivered siRNA Therapeutics. [PDF]

J Clin Med
Crintea A, Bocșan CI, Jianu EM, Șovrea AS, Munteanu C, Kubelac MP, Crăciun AM, Silaghi CN.   +7 more
europepmc   +1 more source

A Lamp2a-linked RNA secreted by ADSCs prevents ENO1-lactylation-glycolysis feedback and cell malignant behavior in triple-negative breast cancer. [PDF]

Cell Death Dis
Cheng S, Xia B, Li L, Zhao S, Zhang Q, Hui X, Liu X, Xiong W, Chen W, Zhang Y.   +9 more
europepmc   +1 more source

Celastrol increases anoikis sensitivity to suppress triple-negative breast cancer via EGFR pathway and p-EMT state regulation. [PDF]

Front Pharmacol
Yang J, Wang X, Bai X, Deng R, Ye W, Liu Q, Xing Y, Yao Y, Lyu A, Lu C, Liu Y.   +10 more
europepmc   +1 more source

Assessing the prognostic role of androgen receptor expression in non-metastatic triple-negative breast cancer. [PDF]

Front Oncol
Al-Masri M, Safi Y, Aljalabneh B, Jarah I, Ananzeh H, AlMasri R, Alayyan O, Alawneh F, Almasri M.   +8 more
europepmc   +1 more source